PetVivo Holdings (PETV) Share-based Compensation (2014 - 2026)
PetVivo Holdings' Share-based Compensation was $460,609 in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 245.8% from $133,197 a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
PetVivo Holdings (PETV) Share-based Compensation (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, PetVivo Holdings' Share-based Compensation was $2.21 million through Jun 30, 2026, up 148.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.88 million, up 69.7% from FY2025.
- Share-based Compensation shows a five-year compound annual growth rate of 28.3% (FY2021 to FY2026).
- In earlier fiscal years, Share-based Compensation was $1.11 million in FY2025 (-47.5%), $2.11 million in FY2024 (+44.2%), $1.46 million in FY2023 (+108.1%) and $702,896 in FY2022 (+29.9%).
- Quarterly Share-based Compensation has moved between $90,278 (fiscal Q4 2025) and $699,397 (fiscal Q2 2026) over five years.
- Compared with a year earlier, Share-based Compensation has increased for four straight quarters, with growth averaging 78.6% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q4 2026 (growth of 430.4%); the worst was fiscal Q4 2025 (a decline of 84.2%).
- Per Business Quant data, PETV's Share-based Compensation in the three fiscal quarters before Q1 2027 was $478,837 (Q4 2026), $568,459 (Q3 2026) and $699,397 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 249.00 Mn |
| 10 | PetVivo Holdings | 25.94 Mn | 24.68 Mn | 223,317.00 | 460,609.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 460,609.00 |
| Mar 31, 2026 | 478,837.00 |
| Dec 31, 2025 | 568,459.00 |
| Sep 30, 2025 | 699,397.00 |
| Jun 30, 2025 | 133,197.00 |
| Mar 31, 2025 | 90,278.00 |
| Dec 31, 2024 | 315,806.00 |
| Sep 30, 2024 | 349,141.00 |
| Jun 30, 2024 | 352,295.00 |
| Mar 31, 2024 | 572,346.00 |
| Dec 31, 2023 | 517,390.00 |
| Sep 30, 2023 | 648,023.00 |
| Jun 30, 2023 | 731,987.00 |
| Mar 31, 2023 | 393,183.00 |
| Dec 31, 2022 | 305,971.00 |
| Sep 30, 2022 | 305,971.00 |
| Jun 30, 2022 | 231,231.00 |
| Mar 31, 2022 | 270,413.00 |
| Dec 31, 2021 | 272,717.00 |
| Sep 30, 2021 | 104,092.00 |
API Access
PetVivo Holdings Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PETV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PETV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PETV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();